TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive Capitol Hill: Bills Seeks Coverage for Treatment Of cancers Found in CDC Screening April 2, 1999
TCL Archive Karmanos Cancer Institute, CDC, Blue Cross To Begin Environmental Cancer Program June 4, 2010